Symbol="FRLN"
AssetType="Common Stock"
Name="Freeline TherapeuticsÂ Holdings Plc"
Description="Freeline Therapeutics Holdings plc, a clinical-stage biotechnology company, develops vector-mediated adeno-associated virus (AAV) transforming gene therapies for patients suffering from inherited systemic debilitating diseases. The company is headquartered in Stevenage, the United Kingdom."
CIK="1810031"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="STEVENAGE BIOSCIENCE CATALYST, GUNNELS WOOD ROAD, STEVENAGE, HERTFORDSHIRE, GB"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="11597200"
EBITDA="-84667000"
PERatio="None"
PEGRatio="None"
BookValue="12.89"
DividendPerShare="0"
DividendYield="0"
EPS="-15.81"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.388"
ReturnOnEquityTTM="-0.7"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-15.81"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="13.25"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.559"
EVToRevenue="-"
EVToEBITDA="0.146"
Beta="0.584"
num_52WeekHigh="15.75"
num_52WeekLow="2.11"
num_50DayMovingAverage="3.143"
num_200DayMovingAverage="7.23"
SharesOutstanding="4343500"
DividendDate="None"
ExDividendDate="None"
symbol="FRLN"
open="2.67"
high="2.83"
low="2.67"
price="2.75"
volume="11231.00"
latest_trading_day="2023-07-07"
previous_close="2.71"
change="0.04"
change_percent="1.6636%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="85"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="15"
Volume_recent_avg="119483"
Change_recent_avg="-0.03"
Delta_recent_avg="0.16"
Variance_recent_avg="0.08"
Change_ratio_recent_avg="-2.42"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="15"
Aroon_momentum_negative="85"
image_negative_thumbnail_id_1="1095"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0128.jpeg"
image_negative_thumbnail_id_2="491"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0114.jpeg"
image_neutral_thumbnail_id_1="554"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0045.jpeg"
image_neutral_thumbnail_id_2="576"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0023.jpeg"
image_positive_thumbnail_id_1="650"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0058.jpeg"
image_positive_thumbnail_id_2="649"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0059.jpeg"
image_professor_thumbnail_id_1="1194"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
image_professor_thumbnail_id_2="1172"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
